A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Purpose:
To determine the efficacy of BAY 43-9006 in combination with bicalutamide in patients with
chemo-naïve hormone-refractory prostate cancer.
Hypothesis:
That there will be PSA response when BAY 43-9006 in combination with bicalutamide is given to
patients with chemo-naïve hormone-refractory prostate cancer.